Relationship Between Perioperative Carotid Blood Flow Monitoring and Cerebral Function Protection in Cardiac Surgery
NCT ID: NCT05586347
Last Updated: 2022-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2022-04-22
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Study of Postoperative Delirium and Glymphatic System Function in Cardiac Surgery
NCT06901479
Evaluation of the Ketogenic Diet to Improve Post Operative Cognitive Decline in Cardiac Surgery
NCT06480708
Association Between the Brain Excitability and Postoperative Delirium in Patients Undergoing Heart Valve Replacement Surgery With Cardiopulmonary Bypass
NCT05001425
Prediction Model of Long-term Cognitive Dysfunction and Delirium After Cardiac Surgery
NCT05972057
Relationship Between Postoperative Delirium and Heart Function in Valvular Surgery
NCT05211934
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group N
Nicardipine was infused after initiation of CPB
Nicardipine
Nicardipine 0.2-0.5μg/(kg·min) was infused at the beginning of CPB.
group C
Give the same volume of normal saline
normal saline
It has the same capacity as group N。
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nicardipine
Nicardipine 0.2-0.5μg/(kg·min) was infused at the beginning of CPB.
normal saline
It has the same capacity as group N。
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2: ASA Ⅱ-Ⅲ, NYHAⅠ-Ⅲ, EF ≥50%
3: CABG under cardiopulmonary bypass
Exclusion Criteria
2: Patients with intellectual disabilities, deafness or other impairments in normal communication
3: Previous neurosurgical procedures and history of cerebral infarction
4: cancer
5: Patients with moderate to severe carotid artery stenosis before operation
6: Patients with obvious abnormal liver and kidney function affecting drug metabolism
7: Patients taking psychotropic drugs
8: Alcoholism, drug addiction, drug dependence
9: The cardiopulmonary bypass time was greater than 120 minutes
60 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanjing First Hospital, Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hongwei Shi
Head of the anesthesia department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
hongwei shi
Role: STUDY_DIRECTOR
Director of anesthesiology department of Nanjing First Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hongwei Shi
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
hongweishi
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.